Carrier for targeting nerve cells

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 14/33 (2006.01) A61K 8/64 (2006.01) A61K 8/66 (2006.01) A61K 38/00 (2006.01) A61K 38/16 (2006.01) A61K 38/48 (2006.01) A61K 47/48 (2006.01) C07K 14/195 (2006.01) C07K 19/00 (2006.01) C12N 1/19 (2006.01) C12N 1/21 (2006.01) C12N 9/50 (2006.01) C12N 9/52 (2006.01) C12N 15/63 (2006.01) C12N 15/66 (2006.01)

Patent

CA 2606030

The present invention relates to a transport protein which can be obtained by modifying the heavy chain of the neurotoxin formed by Clostridium botulinum wherein (i) the protein binds specifically to nerve cells with a higher or lower affinity as the native neurotoxin; (ii) the protein has an increased or reduced neurotoxicity compared to the native neurotoxin, the neurotoxicity being preferably determined in the hemidiaphragma assay; and/or (iii) the protein comprises a lower affinity against neutralizing antibodies compared to the native neurotoxin. The invention also relates to methods for producing the same and the use thereof in cosmetic and pharmaceutical compositions.

L'invention concerne une protéine de transport, obtenue par modification d'une chaîne lourde de neurotoxine comprenant du Clostridium botulinum, (i) la protéine se liant à des cellules nerveuses avec une affinité supérieure ou inférieure à la neurotoxine d'origine ; (ii) la protéine présente neurotoxicité supérieure ou inférieure à la neurotoxine d'origine ; de préférence, la neurotoxicité est déterminée dans l'essai biologique de l'hémidiaphragme ; et/ou (iii) la protéine présente une affinité inférieure, par rapport à la neurotoxine d'origine, avec les anticorps à neutraliser. L'invention concerne également un procédé de production et d'utilisation de ladite protéine dans des compositions pharmaceutiques et cosmétiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Carrier for targeting nerve cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Carrier for targeting nerve cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carrier for targeting nerve cells will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1949541

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.